TY - JOUR
T1 - Assessing 5-year radiographic progression in rheumatoid arthritis patients with moderate disease: findings from a uk multi-centre prospective observational study
AU - Carpenter, L
AU - Norton, S
AU - Nikiphorou, E
AU - Jayakumar, K
AU - McWilliams, DF
AU - Dixey, J
AU - Kiely, P
AU - Walsh, DA
AU - Young, A
N1 - © 2017, The Author(s). Published by BMJ Publishing Group Ltd. on behalf of European Alliance of Associations for Rheumatology, EULAR.
PY - 2025/1/3
Y1 - 2025/1/3
N2 - Background
Early, intensive treatment to achieve remission, or at least low disease target (Treat-to-Target, T2T), is advocated to prevent and/or reduce structural joint damage and disability in early Rheumatoid Arthritis (RA). A recent study shows how patients with moderate disease exhibit similar rates of functional disability and orthopaedic surgical interventions to those patients with high disease1. To our knowledge, no study has looked at longitudinal observational data to investigate the progression of structural joint damage in these patient sub-groups.
Objectives
To investigate the long-term progression of radiographic joint damage in patients with sustained moderate disease activity.
Methods
Demographic, clinical, laboratory and radiographic data from the Early Rheumatoid Arthritis Study (ERAS) was available for 1,465 patients. Radiographic damage was scored using the modified Sharp/van der Heijde (SvdH) method. The original three variable 44 joint count Disease Activity Score (DAS-44) was used. Mean DAS-44 over the first 5 years was estimated for patients with at least two DAS-44 scores. Patients were stratified based on EULARs thresholds of low (3.7) disease. Mixed-effects negative binomial regression modelled patients' radiographic progression over 5 years, whilst controlling for key confounders, including age at onset, sex, rheumatoid factor status and baseline functional disability.
Results
A total of 1,110 patients with 3,751 observations over the 5 year period (mean =3.4 observations per patient) were analysed. 396 (36%), 363 (33%) and 351 (32%) patients were classified in the low, moderate and high DAS-44 groups respectively. The low group had lower SvdH scores at 1 year compared to the moderate group (12.9 vs. 19.2, p
AB - Background
Early, intensive treatment to achieve remission, or at least low disease target (Treat-to-Target, T2T), is advocated to prevent and/or reduce structural joint damage and disability in early Rheumatoid Arthritis (RA). A recent study shows how patients with moderate disease exhibit similar rates of functional disability and orthopaedic surgical interventions to those patients with high disease1. To our knowledge, no study has looked at longitudinal observational data to investigate the progression of structural joint damage in these patient sub-groups.
Objectives
To investigate the long-term progression of radiographic joint damage in patients with sustained moderate disease activity.
Methods
Demographic, clinical, laboratory and radiographic data from the Early Rheumatoid Arthritis Study (ERAS) was available for 1,465 patients. Radiographic damage was scored using the modified Sharp/van der Heijde (SvdH) method. The original three variable 44 joint count Disease Activity Score (DAS-44) was used. Mean DAS-44 over the first 5 years was estimated for patients with at least two DAS-44 scores. Patients were stratified based on EULARs thresholds of low (3.7) disease. Mixed-effects negative binomial regression modelled patients' radiographic progression over 5 years, whilst controlling for key confounders, including age at onset, sex, rheumatoid factor status and baseline functional disability.
Results
A total of 1,110 patients with 3,751 observations over the 5 year period (mean =3.4 observations per patient) were analysed. 396 (36%), 363 (33%) and 351 (32%) patients were classified in the low, moderate and high DAS-44 groups respectively. The low group had lower SvdH scores at 1 year compared to the moderate group (12.9 vs. 19.2, p
U2 - 10.1136/annrheumdis-2017-eular.3893
DO - 10.1136/annrheumdis-2017-eular.3893
M3 - Meeting abstract
SN - 0003-4967
VL - 76
SP - 782
JO - Annals of the Rheumatic Diseases
JF - Annals of the Rheumatic Diseases
M1 - SAT0040
ER -